| |
 |
|
Class Information
Number: 546/279.4
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) or nitrogen as the only ring hetero atoms (class 540, subclass 1) > Hetero ring is six-membered consisting of one nitrogen and five carbons > Additional hetero ring containing > The additional hetero ring is five-membered consisting of one nitrogen and four carbons > Nicotine, per se, or its salts
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7547712 |
Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women |
Jun. 16, 2009 |
| 7501520 |
Regioselective halogenation of nicotine and substituted nicotines |
Mar. 10, 2009 |
| 7452541 |
Hapten-carrier conjugates and uses thereof |
Nov. 18, 2008 |
| 7390907 |
Vanilloid receptor ligands and their use in treatments |
Jun. 24, 2008 |
| 7304160 |
Regiospecific synthesis of nicotine derivatives |
Dec. 4, 2007 |
| 7300956 |
Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
Nov. 27, 2007 |
| 7262060 |
Method for assessing nicotine dependence |
Aug. 28, 2007 |
| 7132545 |
Synthesis of nicotine derivatives from nicotine |
Nov. 7, 2006 |
| 7112678 |
Regiospecific synthesis of nicotine derivatives |
Sep. 26, 2006 |
| 7101896 |
Pharmaceutical compositions and methods for use |
Sep. 5, 2006 |
| 7091357 |
Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies |
Aug. 15, 2006 |
| 7067672 |
Regioselective halogenation of nicotine and substituted nicotines |
Jun. 27, 2006 |
| 6890935 |
Pharmaceutical compositions and methods for use |
May. 10, 2005 |
| 6828336 |
Nicotine-containing, controlled release composition and method |
Dec. 7, 2004 |
| 6743812 |
Pharmaceutical compositions and methods for use |
Jun. 1, 2004 |
| 6656469 |
Nicotine immunogen |
Dec. 2, 2003 |
| 6586449 |
Nicotine-containing, controlled release composition and method |
Jul. 1, 2003 |
| 6277870 |
Use |
Aug. 21, 2001 |
| 6002010 |
Carboxylic acid derivative preparation process |
Dec. 14, 1999 |
| 5876727 |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
Mar. 2, 1999 |
| 5846983 |
Colonic delivery of nicotine to treat inflammatory bowel disease |
Dec. 8, 1998 |
| 5780486 |
Heterocyclic compounds |
Jul. 14, 1998 |
| 5705527 |
Amino acid derivatives |
Jan. 6, 1998 |
| 5703100 |
Modulators of acetylcholine receptors |
Dec. 30, 1997 |
| 5691365 |
Nicotinic receptor antagonists in the treatment of neuropharmacological disorders |
Nov. 25, 1997 |
| 5686484 |
Milbemycin derivatives, their preparation and their use |
Nov. 11, 1997 |
| 5679670 |
Sulfonamides useful as carbonic anhydrase inhibitors |
Oct. 21, 1997 |
| 5625070 |
Preparation of continine by reacting nicotine with bromide and bromate |
Apr. 29, 1997 |
| 5594011 |
Modulators of acetylcholine receptors |
Jan. 14, 1997 |
| 4917120 |
Nicotine impact modification |
Apr. 17, 1990 |
| 4830028 |
Salts provided from nicotine and organic acid as cigarette additives |
May. 16, 1989 |
| 4506682 |
Clear tobacco aroma oil, a process for obtaining it from a tobacco extract, and its use |
Mar. 26, 1985 |
| 4335057 |
4-(2',2,2'-Trihalogenoethyl)-cyclobutane-1-sulfonic acid salts with optically active bases |
Jun. 15, 1982 |
| 4321387 |
Process for the preparation of optically active nicotine analogs |
Mar. 23, 1982 |
| 4299967 |
Process for producing optically active 2-(2,2-dihalogenovinyl)-cyclopropane-1-carboxylic acids substituted in the 3-position, and derivatives thereof, as well as novel 4-(2,2,2-trihalogeno |
Nov. 10, 1981 |
| 4220781 |
Process for preparing 2-alkyl nicotinoids |
Sep. 2, 1980 |
|
|
|
